| scholarly article | Q13442814 |
| P50 | author | Zuzana Hrabovska | Q80552861 |
| P2093 | author name string | Juraj Kopacek | |
| Jaromir Pastorek | |||
| Silvia Pastorekova | |||
| Jana Tomaskova | |||
| Jela Mistrikova | |||
| Katarina Polcicova | |||
| P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
| Characterization of gammaherpesvirus 68 gene 50 transcription | Q33798175 | ||
| Expression of hypoxia-inducible factor 1: mechanisms and consequences | Q33800739 | ||
| Newcastle disease virus (NDV): brief history of its oncolytic strains | Q33841589 | ||
| Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications | Q33899102 | ||
| Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia | Q35019982 | ||
| Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma | Q35967211 | ||
| Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections | Q36163697 | ||
| Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts | Q36609637 | ||
| Oncolytic viruses driven by tumor-specific promoters | Q36754456 | ||
| Hypoxia inducible factor-2alpha in cancer. | Q36778663 | ||
| The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors | Q37247954 | ||
| HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels | Q38346980 | ||
| Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. | Q39876421 | ||
| EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells | Q40219046 | ||
| The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-1alpha | Q40495822 | ||
| Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus | Q40807418 | ||
| Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis | Q40906922 | ||
| Control of Rta expression critically determines transcription of viral and cellular genes following gammaherpesvirus infection | Q41036678 | ||
| Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 | ||
| G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator | Q42833351 | ||
| Hypoxia-mediated tumour targeting | Q44368762 | ||
| Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway | Q44509761 | ||
| Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle | Q45413006 | ||
| Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells | Q46198800 | ||
| Reovirus therapy of lymphoid malignancies | Q48462087 | ||
| Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner | Q62566479 | ||
| Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1 | Q63565692 | ||
| Virological and pathological features of mice infected with murine gamma-herpesvirus 68 | Q67504691 | ||
| Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo | Q67970625 | ||
| Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis | Q77148150 | ||
| P433 | issue | 1-2 | |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 257-262 | |
| P577 | publication date | 2008-01-24 | |
| P1433 | published in | Virus Research | Q15749215 |
| P1476 | title | Up-regulation of Murid herpesvirus 4 ORF50 by hypoxia: possible implication for virus reactivation from latency | |
| P478 | volume | 132 |
| Q91757226 | A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency |
| Q28728172 | Characterization of omental immune aggregates during establishment of a latent gammaherpesvirus infection |
| Q34726144 | Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases |
| Q35867993 | Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection |
| Q39858771 | X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions |
Search more.